Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Athenex, Inc. (ATNX) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Athenex, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1300699.
Total stock buying since 2017: $73,760,831.
Total stock sales since 2017: $33,217,698.
Total stock option exercises since 2017: $2,001,980.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 0 | $0 | 625 | $0 |
| 2022 | 10,000 | $4,220 | 0 | $0 | 215,250 | $0 |
| 2021 | 136,202 | $371,968 | 517,931 | $2,363,588 | 149,000 | $677,950 |
| 2020 | 2,246,450 | $24,412,029 | 0 | $0 | 43,180 | $313,730 |
| 2019 | 2,626,908 | $38,800,265 | 220,053 | $2,602,828 | 124,000 | $564,200 |
| 2018 | 230,908 | $2,980,142 | 1,895,728 | $28,251,282 | 102,000 | $446,100 |
| 2017 | 953,837 | $7,192,207 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-02 | 0 | $0 | 0 | $0 | 625 | $0 |
| 2022-09 | 0 | $0 | 0 | $0 | 132,750 | $0 |
| 2022-08 | 10,000 | $4,220 | 0 | $0 | 82,500 | $0 |
| 2021-11 | 62,952 | $127,853 | 0 | $0 | 0 | $0 |
| 2021-10 | 10,000 | $26,700 | 0 | $0 | 0 | $0 |
| 2021-09 | 50,000 | $161,000 | 0 | $0 | 0 | $0 |
| 2021-05 | 5,000 | $19,950 | 0 | $0 | 99,000 | $450,450 |
| 2021-04 | 8,250 | $36,465 | 0 | $0 | 0 | $0 |
| 2021-03 | 0 | $0 | 517,931 | $2,363,588 | 50,000 | $227,500 |
| 2020-12 | 1,000 | $13,310 | 0 | $0 | 10,000 | $45,500 |
| 2020-11 | 6,000 | $70,450 | 0 | $0 | 0 | $0 |
| 2020-09 | 2,088,450 | $23,039,650 | 0 | $0 | 18,180 | $199,980 |
| 2020-08 | 0 | $0 | 0 | $0 | 15,000 | $68,250 |
| 2020-06 | 3,000 | $38,440 | 0 | $0 | 0 | $0 |
| 2020-03 | 148,000 | $1,250,179 | 0 | $0 | 0 | $0 |
| 2019-12 | 681,000 | $9,579,081 | 0 | $0 | 65,000 | $295,750 |
| 2019-11 | 50,000 | $583,500 | 0 | $0 | 0 | $0 |
| 2019-10 | 124,222 | $1,310,164 | 0 | $0 | 25,000 | $113,750 |
| 2019-09 | 114,000 | $1,591,631 | 0 | $0 | 24,000 | $109,200 |
| 2019-08 | 829,127 | $12,107,220 | 0 | $0 | 0 | $0 |
| 2019-06 | 638,596 | $11,287,592 | 0 | $0 | 0 | $0 |
| 2019-05 | 100,000 | $1,249,000 | 0 | $0 | 0 | $0 |
| 2019-04 | 0 | $0 | 0 | $0 | 10,000 | $45,500 |
| 2019-03 | 89,963 | $1,092,077 | 220,053 | $2,602,828 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-22 | Annoni Joe (Chief Financial Officer) | Option Ex | 625 | .00 | 0 |
| 2022-09-16 | Cook Timothy Devere (See Remarks) | Option Ex | 11,250 | .00 | 0 |
| 2022-09-16 | Lang Daniel (Pres Cell Therapy, VP Corp Dev) | Option Ex | 62,500 | .00 | 0 |
| 2022-08-22 | Wu Jinn (Director) | Buy | 10,000 | .42 | 4,220 |
| 2022-08-03 | Kwan Rudolf (EVP, Chief Medical Officer) | Option Ex | 17,500 | .00 | 0 |
| 2022-08-03 | Wu Jinn (Director) | Option Ex | 7,500 | .00 | 0 |
| 2022-08-03 | Vierling John (Director) | Option Ex | 7,500 | .00 | 0 |
| 2022-08-03 | Yordon Jeffrey (See Remarks) | Option Ex | 12,500 | .00 | 0 |
| 2022-08-03 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 37,500 | .00 | 0 |
| 2021-11-22 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 3,000 | 1.84 | 5,520 |
| 2021-11-18 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 3,000 | 1.87 | 5,610 |
| 2021-11-17 | Kanfer Jordan (Director) | Buy | 4,952 | 2.02 | 10,003 |
| 2021-11-17 | Wu Jinn (Director) | Buy | 30,000 | 2.04 | 61,050 |
| 2021-11-16 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 4,000 | 2.05 | 8,200 |
| 2021-11-16 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 3,000 | 2.06 | 6,180 |
| 2021-11-15 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 5,000 | 2.12 | 10,600 |
| 2021-11-12 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,000 | 2.07 | 20,690 |
| 2021-10-01 | Wu Jinn (Director) | Buy | 10,000 | 2.67 | 26,700 |
| 2021-09-14 | Wu Jinn (Director) | Buy | 50,000 | 3.22 | 161,000 |
| 2021-05-07 | Kwan Rudolf (EVP, Chief Medical Officer) | Option Ex | 24,000 | 4.55 | 109,200 |
| 2021-05-06 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 5,000 | 3.99 | 19,950 |
| 2021-05-05 | Wu Jinn (Director) | Option Ex | 50,000 | 4.55 | 227,500 |
| 2021-05-05 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 25,000 | 4.55 | 113,750 |
| 2021-04-05 | Campbell Kim (Director) | Buy | 8,250 | 4.42 | 36,465 |
| 2021-03-22 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 10,000 | 4.55 | 45,500 |
| 2021-03-19 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 20,000 | 4.55 | 91,000 |
| 2021-03-17 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 20,000 | 4.55 | 91,000 |
| 2021-03-04 | Zuo William Wei (President, China Division) | Sale | 419,931 | 4.52 | 1,898,088 |
| 2021-03-03 | Wu Jinn (Director) | Sale | 98,000 | 4.75 | 465,500 |
| 2020-12-09 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 10,000 | 4.55 | 45,500 |
| 2020-12-01 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 13.31 | 13,310 |
| 2020-11-10 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 11.95 | 11,950 |
| 2020-11-06 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 5,000 | 11.70 | 58,500 |
| 2020-09-24 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 11.95 | 11,950 |
| 2020-09-21 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 12.42 | 12,420 |
| 2020-09-14 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 11.95 | 11,950 |
| 2020-09-14 | Edelman Joseph (10% Owner) | Buy | 1,800,000 | 11.00 | 19,800,000 |
| 2020-09-12 | Fok Manson (Director) | Buy | 16,491 | 11.03 | 181,895 |
| 2020-09-11 | Fok Manson (Director) | Buy | 13,509 | 11.39 | 153,867 |
| 2020-09-11 | Wu Jinn (Director) | Buy | 10,000 | 11.05 | 110,500 |
| 2020-09-11 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 3,000 | 10.95 | 32,888 |
| 2020-09-10 | Kanfer Jordan (Director) | Buy | 450 | 11.49 | 5,170 |
| 2020-09-10 | Davis Stephanie A (Director) | Buy | 10,000 | 11.35 | 113,500 |
| 2020-09-10 | Sze Randoll (Chief Financial Officer) | Buy | 1,000 | 11.40 | 11,400 |
| 2020-09-10 | Wu Jinn (Director) | Buy | 20,000 | 11.15 | 223,000 |
| 2020-09-10 | Yordon Jeffrey (See Remarks) | Option Ex | 18,180 | 11.00 | 199,980 |
| 2020-09-10 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,000 | 11.22 | 112,200 |
| 2020-09-10 | Edelman Joseph (10% Owner) | Buy | 200,000 | 11.24 | 2,248,000 |
| 2020-08-21 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 5,000 | 4.55 | 22,750 |
| 2020-08-20 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 10,000 | 4.55 | 45,500 |
| 2020-06-22 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 1,000 | 12.82 | 12,820 |
| 2020-06-22 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 2,000 | 12.81 | 25,620 |
| 2020-03-27 | Sze Randoll (Chief Financial Officer) | Buy | 1,000 | 8.19 | 8,189 |
| 2020-03-27 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 7.88 | 7,880 |
| 2020-03-25 | Fok Manson (Director) | Buy | 50,000 | 7.25 | 362,500 |
| 2020-03-23 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 6.64 | 6,640 |
| 2020-03-20 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 6.85 | 6,850 |
| 2020-03-19 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 2,000 | 6.60 | 13,200 |
| 2020-03-18 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 4,000 | 5.90 | 23,584 |
| 2020-03-18 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 2,000 | 5.78 | 11,560 |
| 2020-03-17 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 2,000 | 6.90 | 13,800 |
| 2020-03-16 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 2,000 | 7.61 | 15,220 |
| 2020-03-13 | Tsang Benson Kwan Hung (Director) | Buy | 5,000 | 8.39 | 41,950 |
| 2020-03-12 | Tsang Benson Kwan Hung (Director) | Buy | 5,000 | 8.34 | 41,700 |
| 2020-03-12 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 2,000 | 8.19 | 16,379 |
| 2020-03-12 | Yordon Jeffrey (See Remarks) | Buy | 10,000 | 8.14 | 81,430 |
| 2020-03-12 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 6,000 | 8.23 | 49,635 |
| 2020-03-11 | Fok Manson (Director) | Buy | 50,000 | 10.28 | 513,849 |
| 2020-03-09 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 2,000 | 9.79 | 19,574 |
| 2019-12-24 | Edelman Joseph (10% Owner) | Buy | 73,698 | 14.39 | 1,060,514 |
| 2019-12-23 | Edelman Joseph (10% Owner) | Buy | 153,237 | 14.30 | 2,191,289 |
| 2019-12-20 | Edelman Joseph (10% Owner) | Buy | 189,322 | 14.14 | 2,677,013 |
| 2019-12-19 | Edelman Joseph (10% Owner) | Buy | 263,743 | 13.79 | 3,637,015 |
| 2019-12-18 | Wu Jinn (Director) | Option Ex | 20,000 | 4.55 | 91,000 |
| 2019-12-17 | Sze Randoll (Chief Financial Officer) | Buy | 1,000 | 13.25 | 13,250 |
| 2019-12-16 | Wu Jinn (Director) | Option Ex | 30,000 | 4.55 | 136,500 |
| 2019-12-16 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 15,000 | 4.55 | 68,250 |
| 2019-11-07 | Fok Manson (Director) | Buy | 50,000 | 11.67 | 583,500 |
| 2019-10-22 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 5,000 | 4.55 | 22,750 |
| 2019-10-21 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 10,000 | 4.55 | 45,500 |
| 2019-10-17 | Sze Randoll (Chief Financial Officer) | Buy | 1,000 | 10.99 | 10,990 |
| 2019-10-17 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 10,000 | 4.55 | 45,500 |
| 2019-10-17 | Edelman Joseph (10% Owner) | Buy | 50,000 | 10.93 | 546,500 |
| 2019-10-16 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 6,000 | 10.16 | 60,960 |
| 2019-10-16 | Edelman Joseph (10% Owner) | Buy | 67,222 | 10.29 | 691,714 |
| 2019-09-30 | Sze Randoll (Chief Financial Officer) | Buy | 1,000 | 12.62 | 12,620 |
| 2019-09-27 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 3,000 | 12.85 | 38,550 |
| 2019-09-25 | Kwan Rudolf (EVP, Chief Medical Officer) | Option Ex | 24,000 | 4.55 | 109,200 |
| 2019-09-23 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 5,000 | 13.86 | 69,300 |
| 2019-09-16 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 5,000 | 13.57 | 67,850 |
| 2019-09-16 | Edelman Joseph (10% Owner) | Buy | 30,000 | 13.58 | 407,400 |
| 2019-09-13 | Edelman Joseph (10% Owner) | Buy | 56,416 | 14.27 | 805,056 |
| 2019-09-12 | Edelman Joseph (10% Owner) | Buy | 13,584 | 14.05 | 190,855 |
| 2019-08-23 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 5,000 | 14.98 | 74,900 |
| 2019-08-16 | Edelman Joseph (10% Owner) | Buy | 20,000 | 14.96 | 299,200 |
| 2019-08-15 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 1,000 | 14.85 | 14,850 |
| 2019-08-15 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,000 | 14.90 | 149,000 |
| 2019-08-15 | Edelman Joseph (10% Owner) | Buy | 30,000 | 15.00 | 450,000 |
| 2019-08-08 | Edelman Joseph (10% Owner) | Buy | 30,000 | 15.76 | 472,800 |
| 2019-08-07 | Edelman Joseph (10% Owner) | Buy | 733,127 | 14.52 | 10,646,470 |
| 2019-06-26 | Davis Stephanie A (Director) | Buy | 10,000 | 18.00 | 180,000 |
| 2019-06-25 | Edelman Joseph (10% Owner) | Buy | 1,495 | 17.89 | 26,745 |
| 2019-06-24 | Edelman Joseph (10% Owner) | Buy | 20,786 | 17.90 | 372,069 |
| 2019-06-21 | Edelman Joseph (10% Owner) | Buy | 23,073 | 17.85 | 411,853 |
| 2019-06-18 | Edelman Joseph (10% Owner) | Buy | 50,742 | 17.73 | 899,655 |
| 2019-06-17 | Edelman Joseph (10% Owner) | Buy | 130,000 | 17.94 | 2,332,200 |
| 2019-06-14 | Edelman Joseph (10% Owner) | Buy | 324,290 | 17.69 | 5,736,690 |
| 2019-06-13 | Edelman Joseph (10% Owner) | Buy | 75,710 | 17.05 | 1,290,855 |
| 2019-06-06 | Kanfer Jordan (Director) | Buy | 2,500 | 15.01 | 37,525 |
| 2019-05-06 | Edelman Joseph (10% Owner) | Buy | 100,000 | 12.49 | 1,249,000 |
| 2019-04-24 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 10,000 | 4.55 | 45,500 |
| 2019-03-28 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,000 | 12.40 | 124,000 |
| 2019-03-27 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,000 | 12.40 | 124,000 |
| 2019-03-25 | Zuo William Wei (President, China Division) | Buy | 1,000 | 12.47 | 12,470 |
| 2019-03-25 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,000 | 12.45 | 124,500 |
| 2019-03-21 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 1,000 | 12.57 | 12,570 |
| 2019-03-20 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,500 | 12.00 | 126,000 |
| 2019-03-19 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 18,649 | 12.13 | 226,212 |
| 2019-03-18 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 4,000 | 12.52 | 50,080 |
| 2019-03-15 | Trainor-degirolamo Sheldon (Director) | Sale | 54,079 | 11.77 | 636,509 |
| 2019-03-15 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 12,000 | 11.77 | 141,240 |
| 2019-03-14 | Trainor-degirolamo Sheldon (Director) | Sale | 6 | 11.79 | 70 |
| 2019-03-13 | Trainor-degirolamo Sheldon (Director) | Sale | 45,915 | 11.77 | 540,419 |
| 2019-03-13 | Zhang Song-yi (Director) | Sale | 4,432 | 11.82 | 52,386 |
| 2019-03-12 | Zhang Song-yi (Director) | Sale | 83,381 | 11.89 | 991,400 |
| 2019-03-12 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 2,814 | 11.80 | 33,205 |
| 2019-03-11 | Zhang Song-yi (Director) | Sale | 32,240 | 11.85 | 382,044 |
| 2019-03-11 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,000 | 11.78 | 117,800 |
| 2018-12-20 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 10,000 | 4.55 | 45,500 |
| 2018-11-30 | Zhang Song-yi (Director) | Sale | 600,000 | 13.10 | 7,860,000 |
| 2018-11-29 | Zhang Song-yi (Director) | Sale | 400,000 | 13.23 | 5,292,000 |
| 2018-11-19 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 1,000 | 11.70 | 11,697 |
| 2018-11-19 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 10,000 | 11.75 | 117,500 |
| 2018-11-14 | Sze Randoll (Chief Financial Officer) | Buy | 1,000 | 10.26 | 10,255 |
| 2018-11-14 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 15,000 | 10.42 | 156,650 |
| 2018-11-14 | Pedder Simon (See Remarks) | Buy | 2,908 | 10.26 | 29,830 |
| 2018-11-14 | Wu Jinn (Director) | Buy | 10,000 | 10.25 | 102,500 |
| 2018-11-14 | Yordon Jeffrey (See Remarks) | Buy | 9,500 | 10.49 | 99,655 |
| 2018-11-14 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 40,000 | 10.47 | 418,800 |
| 2018-10-15 | Wu Jinn (Director) | Buy | 12,500 | 13.47 | 168,375 |
| 2018-09-27 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 2,000 | 15.66 | 31,320 |
| 2018-09-11 | Wu Jinn (Director) | Option Ex | 32,000 | 4.55 | 145,600 |
| 2018-09-07 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 20,000 | 4.25 | 85,000 |
| 2018-09-06 | Wu Jinn (Director) | Buy | 2,500 | 16.09 | 40,220 |
| 2018-09-06 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 5,000 | 15.84 | 79,200 |
| 2018-08-30 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 20,000 | 4.25 | 85,000 |
| 2018-08-29 | Zhang Song-yi (Director) | Sale | 44,686 | 16.56 | 740,000 |
| 2018-08-28 | Zhang Song-yi (Director) | Sale | 6,343 | 16.95 | 107,513 |
| 2018-08-27 | Zhang Song-yi (Director) | Sale | 30,302 | 17.06 | 516,952 |
| 2018-08-24 | Zhang Song-yi (Director) | Sale | 23,137 | 17.17 | 397,262 |
| 2018-08-24 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Option Ex | 20,000 | 4.25 | 85,000 |
| 2018-08-23 | Mui Bing How Tammy (10% Owner) | Sale | 25,748 | 17.28 | 444,925 |
| 2018-08-22 | Mui Bing How Tammy (10% Owner) | Sale | 56,176 | 17.38 | 976,338 |
| 2018-08-21 | Mui Bing How Tammy (10% Owner) | Sale | 46,558 | 17.07 | 794,745 |
| 2018-08-20 | Mui Bing How Tammy (10% Owner) | Sale | 46,000 | 17.11 | 787,060 |
| 2018-08-20 | Wu Jinn (Director) | Buy | 5,000 | 17.20 | 86,000 |
| 2018-08-17 | Mui Bing How Tammy (10% Owner) | Sale | 70,133 | 17.18 | 1,204,884 |
| 2018-08-16 | Mui Bing How Tammy (10% Owner) | Sale | 61,207 | 16.74 | 1,024,605 |
| 2018-08-15 | Mui Bing How Tammy (10% Owner) | Sale | 43,845 | 16.53 | 724,757 |
| 2018-06-06 | Trainor-degirolamo Sheldon (Director) | Sale | 12,401 | 16.81 | 208,460 |
| 2018-06-05 | Trainor-degirolamo Sheldon (Director) | Sale | 57,421 | 16.82 | 965,821 |
| 2018-06-04 | Trainor-degirolamo Sheldon (Director) | Sale | 31,633 | 16.81 | 531,750 |
| 2018-05-30 | Mui Bing How Tammy (10% Owner) | Sale | 29,416 | 16.11 | 473,891 |
| 2018-05-29 | Mui Bing How Tammy (10% Owner) | Sale | 70,584 | 16.07 | 1,134,284 |
| 2018-05-25 | Mui Bing How Tammy (10% Owner) | Sale | 5,739 | 16.51 | 94,750 |
| 2018-05-24 | Mui Bing How Tammy (10% Owner) | Sale | 3,853 | 16.76 | 64,576 |
| 2018-05-24 | Trainor-degirolamo Sheldon (Director) | Sale | 8,858 | 16.88 | 149,523 |
| 2018-05-23 | Trainor-degirolamo Sheldon (Director) | Sale | 14,584 | 17.03 | 248,365 |
| 2018-05-22 | Trainor-degirolamo Sheldon (Director) | Sale | 5,419 | 17.00 | 92,123 |
| 2018-05-21 | Trainor-degirolamo Sheldon (Director) | Sale | 23,920 | 17.01 | 406,879 |
| 2018-05-18 | Trainor-degirolamo Sheldon (Director) | Sale | 38,729 | 17.01 | 658,780 |
| 2018-05-17 | Mui Bing How Tammy (10% Owner) | Sale | 26,250 | 16.87 | 442,837 |
| 2018-05-17 | Trainor-degirolamo Sheldon (Director) | Sale | 989 | 17.01 | 16,822 |
| 2018-05-16 | Mui Bing How Tammy (10% Owner) | Sale | 44,506 | 16.84 | 749,481 |
| 2018-05-15 | Mui Bing How Tammy (10% Owner) | Sale | 29,244 | 16.93 | 495,100 |
| 2018-05-15 | Trainor-degirolamo Sheldon (Director) | Sale | 38,047 | 17.00 | 646,799 |
| 2018-03-26 | Kwan Rudolf (EVP, Chief Medical Officer) | Buy | 2,000 | 14.65 | 29,300 |
| 2018-03-26 | Wu Jinn (Director) | Buy | 10,000 | 14.66 | 146,600 |
| 2018-03-26 | Yordon Jeffrey (See Remarks) | Buy | 5,000 | 14.69 | 73,450 |
| 2018-03-26 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 12,500 | 14.76 | 184,500 |
| 2018-02-09 | Wu Jinn (Director) | Buy | 10,000 | 13.64 | 136,430 |
| 2018-02-08 | Fok Manson (Director) | Buy | 20,000 | 14.44 | 288,880 |
| 2018-02-08 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 20,000 | 14.39 | 287,900 |
| 2018-02-07 | Fok Manson (Director) | Buy | 30,000 | 14.31 | 429,330 |
| 2017-06-19 | Leung Antony | Buy | 300,000 | .00 | 0 |
| 2017-06-19 | Mui Bing How Tammy | Buy | 328,637 | 11.00 | 3,615,007 |
| 2017-06-19 | Fok Manson | Buy | 300,000 | 11.00 | 3,300,000 |
| 2017-06-19 | Lau Johnson Yiu Nam (CEO and Chairman of the Board) | Buy | 25,200 | 11.00 | 277,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of ATNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Athenex, Inc. (symbol ATNX, CIK number 1300699) see the Securities and Exchange Commission (SEC) website.